Evidence map›Paper›PMID 28585133›Full record

ArticleJournal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban2017

Therapeutic effects of curcumin nanoemulsions on prostate cancer.

Yan-Bin Guan, Shu-Yao Zhou, Yu-Qiong Zhang, Jia-le Wang, Yu-Dong Tian, Yong-Yan Jia, Yan-Jun Sun

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Current Applications of Nanoemulsions in Cancer Therapeutics.Nanomaterials (Basel, Switzerland) · 2019
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yan-Bin GuanSchool of Pharmacy, Henan University of Traditional Chinese Medicine, Zhengzhou, 450001, China. guanyanbin96@126.com.
Shu-Yao ZhouSchool of Pharmacy, Henan University of Traditional Chinese Medicine, Zhengzhou, 450001, China.
Yu-Qiong ZhangSchool of Pharmacy, Henan University of Traditional Chinese Medicine, Zhengzhou, 450001, China.
Jia-le WangSchool of Pharmacy, Henan University of Traditional Chinese Medicine, Zhengzhou, 450001, China.
Yu-Dong TianDepartment of Urology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, China.
Yong-Yan JiaSchool of Pharmacy, Henan University of Traditional Chinese Medicine, Zhengzhou, 450001, China.
Yan-Jun SunSchool of Pharmacy, Henan University of Traditional Chinese Medicine, Zhengzhou, 450001, China. sunyanjun96@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The therapeutic potential of curcumin (Cur) is hampered by its poor aqueous solubility and low bioavailability. The aim of this study was to determine whether Cur nanoemulsions enhance the efficacy of Cur against prostate cancer cells and increase the oral absorption of Cur. Cur nanoemulsions were developed using the self-microemulsifying method and characterized by their morphology, droplet size and zeta potential. The results showed that the cytotoxicity and cell uptake were considerably increased with Cur nanoemulsions compared to free Cur. Cur nanoemulsions exhibited a significantly prolonged biological activity and demonstrated better therapeutic efficacy than free Cur, as assessed by apoptosis and cell cycle studies. In situ single-pass perfusion studies demonstrated higher effective permeability coefficient and absorption rate constant for Cur nanoemulsions than for free Cur. Our study suggested that Cur nanoemulsions can be used as an effective drug delivery system to enhance the anticancer effect and oral bioavailability of Cur.

Indexed as

AnimalsAntineoplastic Agents, PhytogenicApoptosisCaspase 3Caspase 7Cell CycleCell Line, TumorCell SurvivalCurcuminDuodenumEmulsionsGene ExpressionGlycerolHumansIleumIntestinal AbsorptionAntineoplastic Agents, PhytogenicCASP3 protein, humanCASP7 protein, humanCaspase 3Caspase 7cremophorCurcuminEmulsionsGlycerolPolyethylene GlycolsSurface-Active Agentsanticancer efficacycurcuminnanoemulsionoral absorptionprostate cancer

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.